Search - tctmd.com

Displaying 641 - 654 of 654

Sort: Relevancy | Date

News Features

When Paths Diverge—and Converge: Manish and Sahil Parikh Make Their Mark as Brothers, Clinicians, and Educators

Nicole Lou

August 15, 2015

News Daily News

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

Yael L. Maxwell

August 12, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Daily News

Hospitals Seem to Disproportionately Benefit From 2010 Medicare Cuts

June 09, 2015

News Industry News

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

June 09, 2015

News Industry News

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

June 05, 2015

News Daily News

尽管未测得对生活质量有提升作用，但女性患者仍偏向于桡动脉入路的心导管术

Caitlin E. Cox

May 15, 2015

News Features

Physician Dissatisfaction With MOC Goes Mainstream, Inspires Activism

Yael L. Maxwell

May 08, 2015

News Features

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Yael L. Maxwell

June 27, 2014

News Daily News

Physician Partisanship Leans Right but Is in Flux

June 17, 2014

News Conference News ACC 2013

MASS COMM: On-site Surgical Back-up Not Necessary for Elective PCI

Jason Kahn

March 11, 2013

News Daily News

Door-to-Balloon Times Improve Drastically Over 6-Year Period

Jason Kahn

August 22, 2011

News Daily News

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Jason Kahn

August 01, 2011

Advertisement

When Paths Diverge—and Converge: Manish and Sahil Parikh Make Their Mark as Brothers, Clinicians, and Educators

BARI 2D: Increased Risk Factor Control in Patients With Type 2 Diabetes Ups Survival

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Hospitals Seem to Disproportionately Benefit From 2010 Medicare Cuts

First CVD Outcome Trial of a GLP-1 Agonist Finds No Cardiac Risk or Benefit

Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease

尽管未测得对生活质量有提升作用，但女性患者仍偏向于桡动脉入路的心导管术

Physician Dissatisfaction With MOC Goes Mainstream, Inspires Activism

Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices

Physician Partisanship Leans Right but Is in Flux

MASS COMM: On-site Surgical Back-up Not Necessary for Elective PCI

Door-to-Balloon Times Improve Drastically Over 6-Year Period

Low US Participation in NIH-Sponsored CVD Trials Cause for Concern

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content